Professor of Medicine, Yale University
Oncology
Dr. Dennis L. Cooper, MD
|
|
Give Review
Dr. Dennis L. Cooper practices Oncology. He went to Rush Medical College. He received 3 awards: "Top Doctors: New York Metro Area", "CMS Meaningful Use Stage 1 Certification" and "New York Magazine: Top Doctors". Dennis Cooper is a published doctor as well. He has 64 publications published. The latest was: Late solid tumors after treatment for Hodgkin's disease.
Publications
- The use of basiliximab-infliximab combination for the treatment of severe gastrointestinal Acute GvHD.
- A Bone to Pick Regarding Use of Magnetic Resonance Imaging to Begin Treatment in Patients With Asymptomatic Multiple Myeloma.
- Pilot study of sorafenib in relapsed or refractory peripheral and cutaneous T-Cell lymphoma.
- Toxic erythema of chemotherapy following i.v. BU plus fludarabine for allogeneic PBSC transplant.
- Successful collection and engraftment of autologous peripheral blood progenitor Cells in poorly mobilized patients receiving high-dose granulocyte colony-stimulating f...
- Late afternoon dosing of plerixafor for stem Cell mobilization: a practical solution.
- Hematopoietic stem Cell transplantation and the 'eye of the tiger'.
- Toxic erythema of chemotherapy: a useful clinical term.
- Mobilization, collection, and transplantation of peripheral blood hematopoietic progenitor Cells in a patient with multiple myeloma and hemoglobin SC disease.
- Outpatient high-dose melphalan in multiple myeloma patients.
- Recurrence of Lymphoma presenting as asymmetrically increased testicular activity on FDG-PET/CT.
- Lichen sclerosus and eosinophilic fasciitis as manifestations of Chronic graft-versus-host disease: expanding the sclerodermoid spectrum.
- The cutaneous B-Cell lymphoma prognostic index: a novel prognostic index derived from a population-based registry.
- Pneumococcemia as the presenting feature of multiple myeloma.
- A preclinical xenotransplantation animal model to assess human hematopoietic stem Cell engraftment.
- Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification ...
- Systemic Tropheryma whippleii infection associated with monoclonal B-Cell proliferation: a Helicobacter pylori-type pathogenesis?
- HLA matching for hematopoietic stem-Cell transplants.
- Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency.
- Collision tumors: pancreatic adenocarcinoma and mantle Cell lymphoma.
- A Melanoma Brain Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: First Evidence for Fusion in Human Cancer.
- Does lenalidomide plus dexamethasone improve outcome in patients with relapsed multiple myeloma?
- Metastatic myoepithelial Carcinoma of the vulva treated with carboplatin and paclitaxel.
- A simplified approach to stem Cell mobilization in multiple myeloma patients not previously treated with alkylating agents.
- Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor Cell t...
- In vitro collection and posttransfusion enGraftment characteristics of MNCs obtained by using a new separator for autologous PBPC transplantation.
- Assessment of pulmonary and cardiac function after high dose chemotherapy with BEAM and peripheral blood progenitor Cell transplantation.
- A phase I study of paclitaxel for mobilization of peripheral blood progenitor Cells.
- High-dose BEAM chemotherapy with autologous peripheral blood progenitor-Cell transplantation for unselected patients with primary refractory or relapsed Hodgkin''s dis...
- Cisplatin, fluorouracil, and leucovorin inDuction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with adva...
- Allogeneic peripheral blood stem Cell transplantation for high-risk non-Hodgkin''s lymphoma.
- Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical s...
- Spontaneous regression of lymphoproliferative Disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.
- Impact of non-CTCL dermatologic diagnoses and adjuvant therapies on cutaneous T-Cell lymphoma patients treated with total skin electron beam radiation therapy.
- Gallium scans in the management of patients with Hodgkin's Disease: a study of 101 patients.
- Phase II trial of 9-aminocamptothecin as a 72-h infusion in cutaneous T-Cell lymphoma.
- Disseminated intravascular coagulation and excessive fibrinolysis in a patient with metastatic prostate Cancer. Response to epsilon-aminocaproic acid.
- Second solid tumors in patients with Hodgkin's Disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.
- Hyperleukocytosis and retinal hemorrhages after chemotherapy and Filgrastim administration for peripheral blood progenitor Cell mobilization.
- P-glycoprotein expression and multidrug resistance in cutaneous T-Cell lymphoma.
- Thyroid Lymphoma. The case for combined modality therapy.
- Combined modality therapy in previously untreated patients with advanced Hodgkin's Disease: A 24-year follow-up study.
- Burkitt's lymphoma-Leukemia in patients treated for Hodgkin's disease.
- Second solid malignancies after combined modality therapy for Hodgkin's Disease.
- Bazex syndrome (acrokeratosis paraneoplastica). An Analytic review.
- Gallium scans in patients with mediastinal Hodgkin's Disease treated with chemotherapy.
- Brief chemotherapy, involved field radiation therapy, and central Nervous system prophylaxis for paranasal sinus lymphoma.
- Assessment of cardiac and pulmonary function in adult patients with Hodgkin's Disease treated with ABVD or MOPP/ABVD plus adjuvant low-dose mediastinal irradiation.
- Inhibition of poly(adenosine diphosphate-ribose) polymerase by thymidine and thymidine Analogues in L1210 cells and its relationship to the potentiation of the antitum...
- Chlorambucil-induced seizures.
- A phase I pilot study of BCNU plus thymidine in patients with refractory Cancer.
- Primary gastrointestinal Lymphomas.
- Cardiogenic shock due to progression of cutaneous T-Cell lymphoma.
- A population-based trial of beta-carotene chemoprevention of head and neck Cancer.
- Lymphoproliferative disorder of granular lymphocytes associated with severe neutropenia. Response to granulocyte colony-stimulating factor.
- Atrophie blanche in a patient with gamma-heavy-chain Disease.
- PseudoLeukemia after granulocyte colony-stimulating factor therapy.
- Hyperprolactinemic galactorrhea in a patient with Hodgkin's Disease and intense pruritus.
- Cyclosporine treatment of refractory T-Cell lymphomas.
- Application of the Cotswolds Criteria for the assessment of Disease response in patients treated for Hodgkin's Disease.
- Late solid tumors after treatment for Hodgkin's Disease.
- Radiation for early-stage Hodgkin's Disease?
- Interleukin-5 mRNA in three T-Cell lymphomas with eosinophilia.
Schools
Rush University
Yale New Haven Hospital
Presby University Hospital
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Top Doctors: New York Metro Area
- CMS Meaningful Use Stage 1 Certification
- New York Magazine: Top Doctors
Education
-
University of Pittsburgh Medical Center -
Yale-New Haven Hospital -
Rush Medical College
Hospital
-
Yale-New Haven Hospital -
Robert Wood Johnson University Hospital
Drug Facts
| NPI NUMBER | 1154319093 | |
| NPPES Provider LastName | COOPER | |
| NPPES Provider FirstName | DENNIS | |
| NPPES Provider ZIPCode | 065191369 | |
| NPPES Provider State | CT | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 967.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 16.0 | |
| Percent Opioid Claims | 1.65 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1154319093 |
| Last Name Of The Provider | COOPER |
| First Name Of The Provider | DENNIS |
| View All |
Similar Doctors
|
|
Dr. Francine M. Foss, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hari A. Deshpande, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel P. Petrylak, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jill Lacy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stacey M. Stein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Megan A. Baumgart, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harriet M. Kluger, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mario Sznol, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael P. Digiovanna, MD |
|
|
Dr. Sarah B. Goldberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Warren D. Shlomchik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diamando Psyrri, MD
This Doctor is OpenDoctor Recommended.
|